Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit assess and record participant-reported adverse events and related data

摘要

BackgroundParticipant reports of medical histories, adverse events (AE) and non-study drugs are integral to evaluating harm in clinical research. However, interpreting or synthesizing results is complicated if studies use different methods for ascertaining and assessing these data. To explore how these data are obtained in malaria drug studies, a descriptive online survey of clinical researchers was conducted during 2012 and 2013.